PAR PHARMACEUTICAL COMPANIES, INC. Inventory Write-down
PAR PHARMACEUTICAL COMPANIES, INC. reported Inventory Write-down of $5.67 million for the 3-month period ending 2015-06-30, per its 10-Q filed 2015-08-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2015-08-06
- PAR PHARMACEUTICAL COMPANIES, INC. inventory write-down for the quarter ending 2015-06-30 was $5.67M, a 12.91% increase year-over-year.
- PAR PHARMACEUTICAL COMPANIES, INC. inventory write-down for the quarter ending 2015-03-31 was $3.72M, a 66.35% increase year-over-year.
- PAR PHARMACEUTICAL COMPANIES, INC. inventory write-down for the quarter ending 2014-09-30 was $624.00K, a 34.66% decline year-over-year.
- PAR PHARMACEUTICAL COMPANIES, INC. inventory write-down for the quarter ending 2014-06-30 was $5.03M, a 21.74% decline year-over-year.
- PAR PHARMACEUTICAL COMPANIES, INC. inventory write-down for fiscal 2011 was $7.20M, a 5.06% decline from fiscal 2010.
- PAR PHARMACEUTICAL COMPANIES, INC. inventory write-down for fiscal 2010 was $7.58M, a 95.72% increase from fiscal 2009.
- PAR PHARMACEUTICAL COMPANIES, INC. inventory write-down for fiscal 2009 was $3.88M.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|
| 2015-06-30 | $5.67M 10-Q · filed 2015-08-06 | $9.39M 10-Q · filed 2015-08-06 | ||
| 2015-03-31 | $3.72M 10-Q · filed 2015-05-11 | |||
| 2014-09-30 | $624.00K 10-Q · filed 2014-11-12 | $5.65M derived: sum of 2 quarters · filed 2015-08-06 | $7.88M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $5.03M 10-Q · filed 2015-08-06 | $7.26M 10-Q · filed 2015-08-06 | ||
| 2014-03-31 | $2.23M 10-Q · filed 2015-05-11 | |||
| 2013-09-30 | $955.00K 10-Q · filed 2014-11-12 | $7.38M derived: sum of 2 quarters · filed 2014-11-12 | $11.48M 10-Q · filed 2014-11-12 | |
| 2013-06-30 | $6.42M 10-Q · filed 2014-08-11 | $10.53M 10-Q · filed 2014-08-11 | ||
| 2013-03-31 | $4.11M 10-Q · filed 2014-05-15 | |||
| 2012-06-30 | $5.95M 10-Q · filed 2012-08-02 | $8.57M 10-Q · filed 2012-08-02 | $13.02M derived: sum of 3 quarters · filed 2012-08-02 | $14.76M derived: sum of 4 quarters · filed 2012-08-02 |
| 2012-03-31 | $2.62M 10-Q · filed 2012-05-08 | $7.07M derived: sum of 2 quarters · filed 2012-05-08 | $8.81M derived: sum of 3 quarters · filed 2012-05-08 | $9.31M derived: sum of 4 quarters · filed 2012-08-02 |
| 2011-12-31 | $4.45M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $6.19M derived: sum of 2 quarters · filed 2012-02-28 | $6.69M derived: sum of 3 quarters · filed 2012-08-02 | $7.20M 10-K · filed 2012-02-28 |
| 2011-09-30 | $1.74M 10-Q · filed 2011-11-02 | $2.25M derived: sum of 2 quarters · filed 2012-08-02 | $2.75M 10-Q · filed 2011-11-02 | $6.01M derived: sum of 4 quarters · filed 2012-08-02 |
| 2011-06-30 | $504.00K 10-Q · filed 2012-08-02 | $1.01M 10-Q · filed 2012-08-02 | $4.27M derived: sum of 3 quarters · filed 2012-08-02 | $4.37M derived: sum of 4 quarters · filed 2012-08-02 |
| 2011-03-31 | $506.00K 10-Q · filed 2012-05-08 | $3.76M derived: sum of 2 quarters · filed 2012-05-08 | $3.87M derived: sum of 3 quarters · filed 2012-05-08 | $6.36M derived: sum of 4 quarters · filed 2012-05-08 |
| 2010-12-31 | $3.26M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $3.36M derived: sum of 2 quarters · filed 2012-02-28 | $5.85M derived: sum of 3 quarters · filed 2012-02-28 | $7.58M 10-K · filed 2012-02-28 |
| 2010-09-30 | $103.00K 10-Q · filed 2011-11-02 | $2.60M derived: sum of 2 quarters · filed 2011-11-02 | $4.33M 10-Q · filed 2011-11-02 | |
| 2010-06-30 | $2.49M 10-Q · filed 2011-08-03 | $4.22M 10-Q · filed 2011-08-03 | ||
| 2009-12-31 | $3.88M 10-K · filed 2012-02-28 |